Form 4: Director Meghan V. Joyce Reports Stock Transactions in Guardant Health, Inc.

Director Meghan V. Joyce filed a Form 4 disclosing the acquisition of 66 shares of Guardant Health, Inc. common stock on October 4, 2024, through the vesting of restricted stock units.

Summary

• On October 7, 2024, Meghan V. Joyce, a director of Guardant Health, Inc., filed a Form 4 with the SEC.
• The form reports a transaction that occurred on October 4, 2024, where 66 shares of common stock were acquired.
• This acquisition was due to the vesting of restricted stock units.
• The price per share was $0, indicating the vesting of an equity award.
• Following the transaction, Joyce directly owns 10,478 shares of Guardant Health, Inc. common stock.
• Joyce also holds 664 derivative securities in the form of restricted stock units.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates standard compensation practices through equity awards.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders, as it involves a small number of shares acquired through existing equity compensation plans.

Key Dates